Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T29879 | Target Info | |||
Target Name | Integrin alpha-5 (ITGA5) | ||||
Synonyms | VLA-5; Integrin alpha-F; Integrin alpha-5 light chain; Integrin alpha-5 heavy chain; Fibronectin receptor subunit alpha; FNRA; CD49e antigen; CD49e; CD49 antigen-like family member E | ||||
Target Type | Clinical trial Target | ||||
Gene Name | ITGA5 | ||||
Biochemical Class | Integrin | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Integrins | [+] 3 Integrins | + | |||
Interacting Target Name | Integrin beta-1 (ITGB1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VLA-4 subunit beta; MSK12; MDF2; Integrin VLA-4 beta subunit; GPIIA; Glycoprotein IIa; FNRB; Fibronectin receptor subunit beta; Fibronectin receptor beta subunit; CD29 antigen; CD29; Beta(1) integrin | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Co-fractionation | [3] | |||
4 | Co-fractionation | [4] | |||
Interacting Target Name | Integrin alpha-4/beta-1 (ITGA4/B1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Alpha 4 beta 1 integrin; alpha(4)beta(1) integrin | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [5] | |||
Interacting Target Name | Integrin beta-3 (ITGB3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Platelet membrane glycoprotein IIIa; Integrin beta-3; GPIIIa; GP3A; CD61 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-fractionation | [3] | |||
2 | Reconstituted Complex | [6] | |||
Other proteins | [+] 2 Other proteins | + | |||
Interacting Target Name | Fibronectin (FN1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Ugl-Y3; Ugl-Y2; Ugl-Y1; FN; Cold-insoluble globulin; CIG | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-Western | [7] | |||
3 | Reconstituted Complex | [8] | |||
Interacting Target Name | Angiopoietin-2 (ANGPT2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | ANG-2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Reconstituted Complex | [5] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Ubiquitination of alpha 5 beta 1 integrin controls fibroblast migration through lysosomal degradation of fibronectin-integrin complexes. Dev Cell. 2010 Jul 20;19(1):148-59. | ||||
REF 2 | SHARPIN is an endogenous inhibitor of 1-integrin activation. Nat Cell Biol. 2011 Sep 25;13(11):1315-24. | ||||
REF 3 | Panorama of ancient metazoan macromolecular complexes. Nature. 2015 Sep 17;525(7569):339-44. | ||||
REF 4 | A census of human soluble protein complexes. Cell. 2012 Aug 31;150(5):1068-81. | ||||
REF 5 | Gln-362 of angiopoietin-2 mediates migration of tumor and endothelial cells through association with 51 integrin. J Biol Chem. 2014 Nov 7;289(45):31330-40. | ||||
REF 6 | Divalent cations differentially regulate integrin alphaIIb cytoplasmic tail binding to beta3 and to calcium- and integrin-binding protein. J Biol Chem. 1999 Jun 11;274(24):17257-66. | ||||
REF 7 | Proteomic analysis of integrin-associated complexes identifies RCC2 as a dual regulator of Rac1 and Arf6. Sci Signal. 2009 Sep 8;2(87):ra51. | ||||
REF 8 | Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. J Biol Chem. 1992 Mar 25;267(9):5790-6. | ||||
REF 9 | Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res. 2006 Jan 15;66(2):775-83. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.